First-in-Human trial tests new surgery for untamable high blood pressure

NCT ID NCT06216808

Summary

This is the first study in people to test the safety and early effectiveness of a new surgical procedure called HyperQure. The procedure aims to lower blood pressure in patients whose high blood pressure is not controlled despite taking three or more medications. Doctors will perform the surgery on 10 patients and monitor their blood pressure and health for one year.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESISTANT HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Asan Medical Center

    RECRUITING

    Seoul, South Korea

    Contact Email: •••••@•••••

  • Chonnam National University Hospital Hwasun Hospital

    RECRUITING

    Jeonam, Chonnam Province, South Korea

    Contact Email: •••••@•••••

  • Hanyang University Seoul Hospital

    RECRUITING

    Seoul, South Korea

    Contact Email: •••••@•••••

  • Seoul National University Bundang Hospital

    RECRUITING

    Gyeonggi-do, South Korea

    Contact Email: •••••@•••••

  • Seoul National University Hospital

    RECRUITING

    Seoul, South Korea

    Contact Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

  • The Catholic University of Korea, Seoul St. Mary's Hospital

    RECRUITING

    Seoul, South Korea

    Contact Email: •••••@•••••

  • Yonsei University Health System, Severance Hospital

    RECRUITING

    Seoul, South Korea

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.